Authors:
Phillips, JL
Ghadimi, BM
Wangsa, D
Padilla-Nash, H
Worrell, R
Hewitt, S
Walther, M
Linehan, WM
Klausner, RD
Ried, T
Citation: Jl. Phillips et al., Molecular cytogenetic characterization of early and late renal cell carcinomas in Von Hippel-Lindau disease, GENE CHROM, 31(1), 2001, pp. 1-9
Authors:
Phillips, JL
Hayward, SW
Wang, YH
Vasselli, J
Pavlovich, C
Padilla-Nash, H
Pezullo, JR
Ghadimi, BM
Grossfeld, GD
Rivera, A
Linehan, WM
Cunha, GR
Ried, T
Citation: Jl. Phillips et al., The consequences of chromosomal aneuploidy on gene expression profiles in a cell line model for prostate carcinogenesis, CANCER RES, 61(22), 2001, pp. 8143-8149
Authors:
Hilgenfeld, E
Padilla-Nash, H
McNeil, N
Knutsen, T
Montagna, C
Tchinda, J
Horst, J
Ludwig, WD
Serve, H
Buchner, T
Berdel, WE
Schrock, E
Ried, T
Citation: E. Hilgenfeld et al., Spectral karyotyping and fluorescence in situ hybridization detect novel chromosomal aberrations, a recurring involvement of chromosome 21 and amplification of the MYC oncogene in acute myeloid leukaemia M2, BR J HAEM, 113(2), 2001, pp. 305-317
Authors:
Knutsen, T
Rao, VK
Ried, T
Mickley, L
Schneider, E
Miyake, K
Ghadimi, BM
Padilla-Nash, H
Pack, S
Greenberger, L
Cowan, K
Dean, M
Fojo, T
Bates, S
Citation: T. Knutsen et al., Amplification of 4q21-q22 and the MXR gene in independently entry derived mitoxantrone-resistant cell lines, GENE CHROM, 27(1), 2000, pp. 110-116
Citation: E. Schrock et H. Padilla-nash, Spectral karyotyping and multicolor fluorescence in situ hybridization reveal new tumor-specific chromosomal aberrations, SEM HEMATOL, 37(4), 2000, pp. 334-347
Authors:
Macville, M
Schrock, E
Padilla-Nash, H
Keck, C
Ghadimi, BM
Zimonjic, D
Popescu, N
Ried, T
Citation: M. Macville et al., Comprehensive and definitive molecular cytogenetic characterization of HeLa cells by spectral karyotyping, CANCER RES, 59(1), 1999, pp. 141-150